Emily Behnken, - Speech-Language Pathologist in Seattle, WA

Emily Behnken, is a Speech-language Pathologist based in Seattle, Washington. Emily Behnken is licensed to practice in Washington (license number LL60783660) and her current practice location is 3939 Leary Way Nw, Seattle, Washington. She can be reached at her office (for appointments etc.) via phone at (206) 691-2598.

NPI number for Emily Behnken is 1265950182 and her current mailing address is Po Box 80827, Seattle, Washington. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1265950182.

Contact Information

Emily Behnken,
3939 Leary Way Nw,
Seattle, WA 98107-5043
(206) 691-2598
Not Available



Healthcare Provider's Profile

Full NameEmily Behnken
GenderFemale
SpecialitySpeech-language Pathologist
Location3939 Leary Way Nw, Seattle, Washington
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1265950182
  • Provider Enumeration Date: 08/30/2017
  • Last Update Date: 03/17/2018

Medical Identifiers

Medical identifiers for Emily Behnken such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1265950182NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist LL60783660 (Washington)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Emily Behnken is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Emily Behnken,
Po Box 80827,
Seattle, WA 98108-0827

Ph: (206) 691-2598
Emily Behnken,
3939 Leary Way Nw,
Seattle, WA 98107-5043

Ph: (206) 691-2598

News Archive

Tetraphase to present its study on novel classes of antibiotics to treat drug-resistant infections

Tetraphase Pharmaceuticals Inc., a biopharmaceutical company capitalizing on breakthrough synthetic chemistry technology announced today that it will present three (3) posters and deliver a slide presentation on the synthesis and antibacterial activity of analogs from several novel classes of antibiotics to treat drug-resistant infections at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA.

Multimillion-dollar electron microscope unveils shapes of viruses and proteins

With a multimillion-dollar electron microscope and computer programs that can pick out the shapes of structures only six atoms wide, Dr. Wah Chiu and his colleagues at Baylor College of Medicine in Houston are attempting to explain the intricate structures of viruses and proteins.

Anti-TNF therapies may reduce Alzheimer's risk among people with rheumatoid arthritis

Anti-TNF therapies commonly used to treat rheumatoid arthritis have been found to potentially reduce the risk of developing Alzheimer's dementia among people with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

Data show that HCV genotype-1 infected patients may benefit from faldaprevir

Data show that Boehringer Ingelheim's second-generation protease inhibitor faldaprevir, when used in combination with pegylated interferon and ribavirin, was effective even with the presence of naturally-occurring mutant variants of the hepatitis C virus, such as the NS3 Q80K polymorphism

Read more News

› Verified 1 days ago


Speech-Language Pathologist in Seattle, WA

Amy L Donaldson, PH.D., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: University Of Washington Autism Ctr, Box 357920, Seattle, WA 98195
Phone: 206-897-1801    
Ms. Carol L Ray, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4507 Sunnyside Ave N, Unit D, Seattle, WA 98103
Phone: 206-849-3937    
Ms. Linda E Eblen, MA
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4800 Sand Point Way Ne, Mail Stop W-6839, Seattle, WA 98105
Phone: 206-987-6164    
Mrs. Genevieve Houdet-cote, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1100 9th Ave, Ms:h4-pmr, Seattle, WA 98101
Phone: 206-341-0461    
Daelene King,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 9100 5th Ave Ne, Seattle, WA 98115
Phone: 206-526-2662    
Molly Beier,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 325 9th Ave, Seattle, WA 98104
Phone: 206-744-3000    
Vassalo Speech And Language Llc
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 2300 W Bertona St, Seattle, WA 98199
Phone: 978-444-0321    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.